The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    INTERVIEWTati Gabrielle, actress of Korean, African-American descent, feels proud of her heritage

  • 3

    China expresses 'strong dissatisfaction' over US shooting down balloon

  • 5

    US shoots down suspected Chinese spy balloon with a single missile

  • 7

    Decoding success factors of NewJeans: How is it different?

  • 9

    VIDEOFilipina K-pop idol and K-drama actress react to stereotypes about the Philippines

  • 11

    LG publishes Korea's first group-level net zero report

  • 13

    Search under way for 9 missing after fishing boat capsizes

  • 15

    Conflict reignites over relocation of POSCO Holdings to Pohang

  • 17

    Dangerously cold temperatures envelop Northeast

  • 19

    Hyundai Motor's technology helps team become WTCR double champion

  • 2

    2-year work experience prerequisite lifted for foreign shipyard welders

  • 4

    Families of Itaewon victims on collision course with Seoul City

  • 6

    President Yoon at odds with politician who helped him win election

  • 8

    'Hype Boy' by NewJeans reaches 200 mil. Spotify streams

  • 10

    9 fishermen, including 2 Vietnamese, missing in boat incident

  • 12

    Reclusive fashion icon Martin Margiela makes comeback as artist with eerie wonderland of human bodies

  • 14

    More than 2,000 foreign workers to be hired at Korean shipyards this month

  • 16

    FSC approves security token transactions in Korea

  • 18

    Japan PM Kishida fires aide over same-sex couple outburst

  • 20

    Brazil scuttles warship in Atlantic despite pollution concerns

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
Bio
  • Tech
  • Bio
  • Companies
Tue, February 7, 2023 | 01:15
[INTERVIEW] Korea should strengthen ecosystem for clinical trials
INTERVIEWKorea should strengthen ecosystem for clinical trials
Over the last few years, the government has been supporting its strategy to help the country rise as a biotechnology hub in Asia given Korea's long-time competiveness in product manufacturing. The country's advantages in terms of having excellent infrastructure, workforce and IT platform have truly been beneficial amid COVID-19 as a number of biotechnology companies, includin...
Kim Yoo-chul | 2022-06-02 15:24
Samsung Biologics establishes one-stop mRNA vaccine production capability at Songdo plant
Samsung Biologics establishes one-stop mRNA vaccine production capability at Songdo plant
Samsung Biologics, the biotech arm of Korea's Samsung Group, has established a one-stop production capability for manufacturing messenger RNA (mRNA) vaccines by newly adding an mRNA vaccine substance production facility at the plant, a company official said Thursday.
2022-06-02 11:21
[INTERVIEW] Immunomic Therapeutics CEO expects meaningful test results for brain tumor drug
INTERVIEWImmunomic Therapeutics CEO expects meaningful test results for brain tumor drug
William Hearl, CEO of Immunomic Therapeutics, the U.S. subsidiary of the Korean biotech company, HLB, said that the company expects meaningful test results from its Phase 2 clinical trials of a drug for glioblastoma by August of this year at the latest.
Baek Byung-yeul | 2022-05-26 16:03
HLB gets positive Phase 3 data with liver cancer treatment
HLB gets positive Phase 3 data with liver cancer treatment
HLB has taken a step closer to the global commercialization of its anticancer treatment Rivoceranib as it secured statistical significance in Phase 3 global clinical trials of the drug, according to the local biotech company, Sunday.
Baek Byung-yeul | 2022-05-15 16:23
Lotte seeks to acquire US CMO plant to enter bioindustry
Lotte seeks to acquire US CMO plant to enter bioindustry
Lotte Group is in the process of acquiring a bioindustry contract manufacturing (CMO) plant in the U.S., according to the investment banking industry, Thursday. The move comes after the conglomerate declared the bioindustry as its new growth engine. CMOs specialize in producing biopharmaceuticals developed by other companies.
Kim Hyun-bin | 2022-05-05 14:46
CHA Biotech's US subsidiary opens CDMO plant in Texas
CHA Biotech's US subsidiary opens CDMO plant in Texas
Matica Biotechnology, a U.S. affiliate of CHA Biotech, has opened a cell and gene therapy manufacturing facility in College Station, Texas, according to the cell therapeutics and stem cell developer affiliate of CHA Medical & Bio Group, Wednesday.
Lee Kyung-min | 2022-05-04 15:53
Osstem Implant posts record profits for Q1
Osstem Implant posts record profits for Q1
Osstem Implant posted a record operating profit for the first quarter, the dental equipment manufacturer said Friday.
Baek Byung-yeul | 2022-04-29 16:30
HLB posts earnings surprise in Q1
HLB posts earnings surprise in Q1
Local biotech company HLB posted sales and operating profit records for the first quarter. The company announced on April 25 that its quarterly sales rose a whopping 1,052 percent from the same period in 2021 to 63.4 billion won ($50.8 million). Its operating profit also came to 18.8 billion won to turn into a surplus. Both sales and operating profit figures were the highest ...
Baek Byung-yeul | 2022-04-26 15:12
Moon hails Phase 3 trial of SK Bioscience's COVID-19 vaccine
Moon hails Phase 3 trial of SK Bioscience's COVID-19 vaccine
President Moon Jae-in praised a successful Phase 3 trial of the nation's first homegrown COVID-19 vaccine, developed by SK Bioscience, Tuesday.
2022-04-26 15:09
Yoon to visit headquarters of homegrown COVID-19 vaccine
Yoon to visit headquarters of homegrown COVID-19 vaccine
President-elect Yoon Suk-yeol will visit homegrown vaccine producer SK Bioscience on Monday and emphasize vaccine sovereignty amid the country's fight against the novel coronavirus, his spokesperson said.
2022-04-25 10:58
1234 5 67
Top 10 Stories
1[VIDEO] Filipina K-pop idol and K-drama actress react to stereotypes about the Philippines VIDEOFilipina K-pop idol and K-drama actress react to stereotypes about the Philippines
2US literary agent reflects on personal journey to discover Korea in new book US literary agent reflects on personal journey to discover Korea in new book
3[ANALYSIS] New order prevails in global battery industry ANALYSISNew order prevails in global battery industry
4[INTERVIEW] Saudi Arabia seeks greater cooperation with Korea in NEOMINTERVIEWSaudi Arabia seeks greater cooperation with Korea in NEOM
5[Video] How Koreans' favorite convenience store foods are made in factories VideoHow Koreans' favorite convenience store foods are made in factories
6Why Galaxy Book3 draws more attention than S23 smartphones Why Galaxy Book3 draws more attention than S23 smartphones
7Debate heats up over chemical castration of more sex offenders Debate heats up over chemical castration of more sex offenders
8Renowned American economist to discuss China issues at Seoul webinar Renowned American economist to discuss China issues at Seoul webinar
9Opposition party's attempt to enact Korean version of IRA triggers concernsOpposition party's attempt to enact Korean version of IRA triggers concerns
10Argentina hopes to strengthen nuclear cooperation with KoreaArgentina hopes to strengthen nuclear cooperation with Korea
DARKROOM
  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

  • World Cup 2022 France vs Morocco

    World Cup 2022 France vs Morocco

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group